Status:
COMPLETED
Evaluation of the Extension at Community Level of Safe Male Circumcision (ANRS 12126 ORANGE FARM 2)
Lead Sponsor:
French National Agency for Research on AIDS and Viral Hepatitis
Conditions:
HIV Infections
Eligibility:
MALE
Phase:
NA
Brief Summary
This study is aimed at demonstrating whether or not Male Circumcision can be used as an effective public health prevention tool that will have an impact on HIV prevalence in the South African populati...
Detailed Description
A randomized, controlled trial (ANRS 1265) conducted in Orange Farm (South Africa) has demonstrated that male circumcision (MC) can reduce the risk of HIV acquisition by more than 50% among young men....
Eligibility Criteria
Inclusion
- being uncircumcised
- living in Orange Farm (South Africa) for more than 3 months
- agreeing to follow the instructions given by doctors, nurses and/or staff, and in particular to abstain from sex for 6-weeks after being circumcised
- having understood and sign a consent form written in their own language
- for those younger than 18 years of age having a written authorization from one parent or guardian and having signed an assent form.
Exclusion
- subjects with contraindications for male circumcision
- allergy to anesthesia
- hemophilia or bleeding disorders
- genital ulceration or other symptoms of sexually transmitted infections
- signs of infections or AIDS
- abnormal genital anatomy
- history of diabetes
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
27000 Patients enrolled
Trial Details
Trial ID
NCT00623051
Start Date
January 1 2008
End Date
December 1 2012
Last Update
July 17 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Male Circumcision Centre
Orange Farm, Johannesburg, South Africa